A patent foramen ovale (PFO), or what we call the hole that forms between the left and right atria of the heart, is relatively common and is known to occur in about one (1) out of four (4) people. The closure of this PFO brings...
Most Recent Articles
Alirocumab’s Effects on Coronary Plaque: The PACMAN-AMI Clinical Trial
Schwartz et al (2018) reported that previous results under the ODYSSEY OUTCOMES trial showed the risk-reducing effect of alirocumab, a proprotein convertase subtilisin-kexin type 9 inhibitor (PCSK9i), when added to high-intensity...
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy
The Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial (REDUCE-IT) earlier reported a 25% decrease in relative risk for major adverse cardiovascular events when using ethyl eicosapentaenoic acid (icosapent...
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
Tranexamic acid (TXA) has long been used to prevent excessive blood loss in patients undergoing cardiac surgery. However, its effects on non-cardiac surgery patients post-operation are still unclear. This particular randomized...
Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)
Patients who suffer acute decompensated heart failure (ADHF) often use diuretic treatments. After all, heart complications of this nature are often accompanied by elevated blood pressure; diuretic treatments reduce this by...